Arovella Therapeutics Quote - ALA

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.20

Bid

0.20

Offer

0.205

Volume

690,676

0.195 Day's Range 0.205

0.105 52 Week Range 0.21

Market Cap

210.031M

Previous Close

0.195

Open

0.195

Last Trade

838

0.2

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,316,046

Shares Outstanding

1,050,156,236

Dividend Yield

PE Ratio

-24.10

Earnings Per Share (EPS)

-0.01

Revenue

1.95M

Net Profit

-8.75M

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

www.sudapharma.com

Headquarters

Melbourne, Victoria, Aus

Founded

Arovella Therapeutics Ltd is listed in the Surgical,med Instr,apparatus sector of the Australian Stock Exchange with ticker ALA. The last closing price for Arovella Therapeutics was AUD0.20. Over the last year, Arovella Therapeutics shares have traded in a share price range of AUD 0.105 to AUD 0.21.

Arovella Therapeutics currently has 1,050,156,236 shares in issue. The market capitalisation of Arovella Therapeutics is AUD204.78 million. Arovella Therapeutics has a price to earnings ratio (PE ratio) of -24.10.

Alcatel-Lucent Introduces New IP Routers to Extend Advanced Mobile, Business and Residential Services to Smaller Markets

New smaller scale platforms allow service providers to extend advantages of Service Routing to furthest reaches of IP network edge at a more economical price point PARIS, Oct. 28 /PRNewswire/...

Amsterdam Public Library Selects Converged IP Solution From Alcatel-Lucent for State of the Art Voice and Data Network

PARIS, July 3 /PRNewswire-FirstCall/ -- The Amsterdam Public Library has selected Alcatel-Lucent's IP (Euronext Paris and NYSE:ALU) technology as the foundation of a comprehensive communications...

China Unicom Selects Alcatel-Lucent IP Service Routers for Nationwide Network Transformation

PARIS, July 3 /PRNewswire-FirstCall/ -- Alcatel-Lucent (Euronext Paris and NYSE: ALU) today announced that its industry-leading IP routing solution has been selected by China Unicom, a leading...

Alcatel-Lucent Announces Software Platform That Lets Mobile Operators Capitalize on the Increasing Demand for Mobile Content Sho

PARIS, June 13 /PRNewswire-FirstCall/ -- Alcatel-Lucent (Euronext Paris and NYSE: ALU) today announced the availability of the enhanced Alcatel-Lucent 5965 Mobile Content Platform, a powerful...

Vodafone and Alcatel-Lucent Cooperate to Deliver 32nd America's Cup Competition Live to Mobile Users in Spain

VALENCIA, Spain, June 1 /PRNewswire-FirstCall/ -- Vodafone and Alcatel-Lucent (Euronext Paris and NYSE: ALU) today announced a cooperation agreement to deliver the award-winning America's Cup...

Alcatel Alenia Space Signs a Euro 661 Million Contract With Globalstar to Build Their Second-Generation LEO Satellite Constellat

PARIS, December 4 /PRNewswire-FirstCall/ -- Alcatel Alenia Space today announced it has signed a Euro 661 million contract with Globalstar, Inc. (NASDAQ:GSAT), a leading provider of mobile...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.025	14.2857142857	0.175	0.205	0.175	1615188	0.18817432	DE
4	0.025	14.2857142857	0.175	0.205	0.1675	1449150	0.18359493	DE
12	0.01	5.26315789474	0.19	0.21	0.16	1316046	0.18501983	DE
26	0.03	17.6470588235	0.17	0.21	0.13	1328028	0.17338242	DE
52	0.065	48.1481481481	0.135	0.21	0.105	1602849	0.153288	DE
156	0.16	400	0.04	0.21	0.02	1942990	0.08517328	DE
260	0.151	308.163265306	0.049	0.21	0.02	1861411	0.08365624	DE

ALA - Frequently Asked Questions (FAQ)

What is the current Arovella Therapeutics share price?

The current share price of Arovella Therapeutics is AUD 0.20

How many Arovella Therapeutics shares are in issue?

Arovella Therapeutics has 1,050,156,236 shares in issue

What is the market cap of Arovella Therapeutics?

The market capitalisation of Arovella Therapeutics is AUD 204.78M

What is the 1 year trading range for Arovella Therapeutics share price?

Arovella Therapeutics has traded in the range of AUD 0.105 to AUD 0.21 during the past year

What is the PE ratio of Arovella Therapeutics?

The price to earnings ratio of Arovella Therapeutics is -24.1

What is the cash to sales ratio of Arovella Therapeutics?

The cash to sales ratio of Arovella Therapeutics is 105.26

What is the reporting currency for Arovella Therapeutics?

Arovella Therapeutics reports financial results in AUD

What is the latest annual turnover for Arovella Therapeutics?

The latest annual turnover of Arovella Therapeutics is AUD 1.95M

What is the latest annual profit for Arovella Therapeutics?

The latest annual profit of Arovella Therapeutics is AUD -8.75M

What is the registered address of Arovella Therapeutics?

The registered address for Arovella Therapeutics is LEVEL 3, 62 LYGON STREET, CARLTON, MELBOURNE, VICTORIA, 3053

What is the Arovella Therapeutics website address?

The website address for Arovella Therapeutics is www.sudapharma.com

Which industry sector does Arovella Therapeutics operate in?

Arovella Therapeutics operates in the SURGICAL,MED INSTR,APPARATUS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CDXOACardieX Limited	AUD 0.03 (76.47%)	2.19M
AQNAquirian Limited	AUD 0.295 (63.89%)	1.08M
CUFOCuFe Ltd	AUD 0.003 (50.00%)	301k
AQDAusquest Limited	AUD 0.033 (50.00%)	54.32M
LYNLycaon Resources Ltd	AUD 0.245 (48.48%)	642.61k
RADORadiopharm Theranostics Ltd	AUD 0.002 (-50.00%)	327.64k
RPMORPM Automotive Group Limited	AUD 0.002 (-50.00%)	2.21M
NHEONoble Helium Ltd	AUD 0.001 (-50.00%)	20k
PRSOAProspech Limited	AUD 0.001 (-50.00%)	66.67k
HFYHubify Limited	AUD 0.007 (-36.36%)	13.82M
ATHOAlterity Therapeutics Limited	AUD 0.004 (0.00%)	86.56M
AQDAusquest Limited	AUD 0.033 (50.00%)	54.32M
SYASayona Mining Limited	AUD 0.023 (-4.17%)	41.31M
BTRBrightstar Resources Limited	AUD 0.021 (0.00%)	36.06M
TMKTMK Energy Ltd	AUD 0.0025 (0.00%)	32.33M